133 related articles for article (PubMed ID: 6268593)
1. Effect of combination of cefsulodin and mecillinam.
Kondo M; Tsuchiya K
J Antibiot (Tokyo); 1981 Jun; 34(6):727-38. PubMed ID: 6268593
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of cephalexin with mecillinam.
Otsuki M
J Antibiot (Tokyo); 1981 Jun; 34(6):739-52. PubMed ID: 6268594
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
Neu HC
Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
[TBL] [Abstract][Full Text] [Related]
4. [Antibacterial activities of monobactams against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
[TBL] [Abstract][Full Text] [Related]
5. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
Chattopadhyay B; Hall I
J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin.
Toda M; Arao N; Nohara C; Susaki K; Tachibana A
Antimicrob Agents Chemother; 1985 Apr; 27(4):565-9. PubMed ID: 3890729
[TBL] [Abstract][Full Text] [Related]
7. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
[TBL] [Abstract][Full Text] [Related]
8. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
Sakamoto M; Ishikura T; Fukagawa Y
J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679
[TBL] [Abstract][Full Text] [Related]
9. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam.
Perea EJ; Palomares JC; García-Iglesias MC
Chemotherapy; 1980; 26(4):282-8. PubMed ID: 6248300
[TBL] [Abstract][Full Text] [Related]
12. Cefotetan: profile of in-vitro activity.
Bauernfeind A
J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
[TBL] [Abstract][Full Text] [Related]
13. Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.
Kramer MJ; Mauriz YR; Timmes MD; Robertson TL; Cleeland R
Am J Med; 1983 Aug; 75(2A):30-41. PubMed ID: 6311003
[TBL] [Abstract][Full Text] [Related]
14. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria].
Suzuki Y; Nishinari C; Endo H; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Aug; 56(4):309-35. PubMed ID: 14567255
[TBL] [Abstract][Full Text] [Related]
15. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--II. Gram-negative bacteria].
Suzuki Y; Nishinari C; Endo H; Tamura C; Jinbo K; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Apr; 55(2):154-80. PubMed ID: 12071094
[TBL] [Abstract][Full Text] [Related]
16. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
Stille W; Bischof-Léger E; Helm EB
Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
18. In vitro interaction between mecillinam and piperacillin-tazobactam in the presence of azithromycin against members of the Enterobacteriaceae family and Pseudomonas aeruginosa.
Maioli E; Debbia EA; Gualco L; Marchese A
New Microbiol; 2008 Jan; 31(1):37-46. PubMed ID: 18437840
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibilities of clinical isolates to antibacterial agents. A study mainly focused on ofloxacin (the second report). Reported by the Research Group for Testing ofloxacin Susceptibility on Clinical Isolates].
Kosakai N
Jpn J Antibiot; 1989 May; 42(5):1125-65. PubMed ID: 2664255
[TBL] [Abstract][Full Text] [Related]
20. Effect of combination of cefsulodin and beta-lactam antibiotics against Serratia marcescens.
Kondo M; Tsuchiya K
J Antibiot (Tokyo); 1981 Oct; 34(10):1327-33. PubMed ID: 7031032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
